Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.555, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab knocks out multiple sclerosis
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
Access to resources
Recommend
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Natalizumab in multiple sclerosis: proceed with caution?
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
Natalizumab benefits QOL in multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 577, 2009-01 ,pp. :